Gilead Sciences (GILD) Debt Ratio (2009 - 2026)

Gilead Sciences (GILD) reported Debt Ratio of 0.39 for Q1 2026, down 10.89% on a YoY basis from 0.44 in Q1 2025, and down 6.74% quarter-over-quarter from 0.42 in Q4 2025.

Gilead Sciences (GILD) Debt Ratio (2009 - 2026) Analysis & Trends

Gilead Sciences has reported Debt Ratio for 18 years, with the latest figure at 0.39 in Q1 2026.

  • For the quarter ending Q1 2026, Debt Ratio fell 10.89% year-over-year to 0.39; the trailing twelve-month figure through Mar 2026 stood at 0.39 (down 10.89% YoY), and the FY2025 full-year result was 0.42, down 6.69% from the prior year.
  • Debt Ratio for Q1 2026 stood at 0.39, down from 0.42 in the prior quarter.
  • The five-year high for Debt Ratio was 0.45 in Q4 2024, with the low at 0.39 in Q1 2026.
  • Historically, Debt Ratio has averaged 0.42 across 5 years, with a median of 0.42 in 2022.
  • Annual changes were most pronounced in 2024 — Debt Ratio rose 12.57% — and 2026, when it retreated 10.89%.
  • Gilead Sciences' Debt Ratio stood at 0.4 in 2022, then grew by 0.7% to 0.4 in 2023, then advanced by 12.57% to 0.45 in 2024, then slipped by 6.69% to 0.42 in 2025, then slipped by 6.74% to 0.39 in 2026.
  • The last three Debt Ratio figures came in at 0.39 (Q1 2026), 0.42 (Q4 2025), and 0.43 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -0.22
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 0.37
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 0.27
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 0.47
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 0.38
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 0.62
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 0.39
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 0.31
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 0.51
10 Novartis Ag 109.78 Bn 109.09 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 0.39
Dec 31, 2025 0.42
Sep 30, 2025 0.43
Jun 30, 2025 0.45
Mar 31, 2025 0.44
Dec 31, 2024 0.45
Sep 30, 2024 0.43
Jun 30, 2024 0.44
Mar 31, 2024 0.45
Dec 31, 2023 0.40
Sep 30, 2023 0.40
Jun 30, 2023 0.40
Mar 31, 2023 0.41
Dec 31, 2022 0.40
Sep 30, 2022 0.40
Jun 30, 2022 0.42
Mar 31, 2022 0.42
Dec 31, 2021 0.39
Sep 30, 2021 0.41
Jun 30, 2021 0.44